President, Chief Executive Officer, and Member of the Board of Directors
Chief Human Resources Officer
Chief Financial Officer
Senior Vice President, Operations
Senior Vice President, Market Access and Reimbursement
Chief Technology Officer
Executive Vice President and Chief Medical Officer
Senior Vice President, Marketing, International Sales & Customer Success
Senior Vice President, US Sales
Chief Legal & Compliance Officer
HeartFlow Analysis is consisted of four main functions; FFRCT, Planner, Roadmap, and Plaque. All four functions are cleared for clinical use in the United States, Bahrain, Israel, and United Arab Emirates. Only FFRCT and Planner functions are cleared cleared for clinical use in Europe, United Kingdom, Australia, Canada, and Japan. Please see HeartFlow Analysis Indications for Use and Instructions for Use for more information.
© 2024 HeartFlow, Inc. | HeartFlow and the HeartFlow logo are registered trademarks of HeartFlow, Inc. Additionally, RoadMap is claimed as a trademark of HeartFlow, Inc. www.heartflow.com | 331 E Evelyn Ave, Mountain View, CA 94041
President, Chief Executive Officer, and Member of the Board of Directors
John brings more than 20 years of experience providing strategic oversight to deliver operational excellence and outstanding performance. Most recently, John served as Vice President and General Manager of the Aortic business at Medtronic. He also served in key leadership roles for Medtronic’s Cardiovascular and Diabetes Groups, including Vice President of the Americas region for the Insulin Pump and Continuous Glucose Monitoring business unit and Vice President for Asia Pacific.
John earned his BA from Duke University and his MBA from Northwestern’s Kellogg School of Management.
Chief Human Resources Officer
Stephanie has held HR leadership positions among some of the world’s leading organizations, including Edwards Lifesciences, Johnson and Johnson, Hologic, and Allergan. Most recently, she has spent time at Hugel Aesthetics, a growth-focused multinational organization where she was instrumental in growing the business more than 400% in less than two years.
Stephanie received her undergraduate degree from California State Polytechnic University, Pomona, and holds an MBA from Walden University.
Chief Financial Officer
Vikram Verghese, CFA, is the Chief Financial Officer of HeartFlow, where he oversees financial planning and analysis, accounting, fundraising, investor relations, business development, and global strategy. He works closely with cross-functional teams to align financial operations with strategic objectives, enabling the company’s growth and operational efficiency.
Since joining HeartFlow in 2021, Vikram has held leadership roles in Business Development, Strategy, and Product Management. His prior experience includes senior roles at Medtronic and Verily Life Sciences, with expertise spanning global marketing, regulatory and clinical affairs, business development, and cross-functional operations.
Vikram holds a Master of Science in Biomedical Engineering from the University of Southern California, an MBA from The Wharton School, and a Bachelor of Engineering in Electrical Engineering from Anna University. Vikram is also a CFA charter holder.
Senior Vice President, Operations
Kathleen is an accomplished Inside Sales and Customer Care executive with more than 15 years of experience. Her expertise spans driving process improvement and operational excellence, utilizing metrics/analytics to deliver results, and leading organizations through large-scale expansion. Most recently, Kathleen was Senior Director, Inside Sales Initiatives at Alto Pharmacy, a telehealth pharmacy startup. She has held operational leadership roles of increasing responsibility at Cardinal Health, Medtronic, W.W. Grainger and Deloitte Consulting.
Kathleen received undergraduate degrees from the University of Illinois and an MBA from The Wharton School at the University of Pennsylvania.
Senior Vice President, Market Access and Reimbursement
Cara Santillo is the SVP of Market Access and Reimbursement where she is responsible for reimbursement strategy for HeartFlow’s current and future product portfolio. In addition, she works closely with HeartFlow’s sales team and customers on cardiovascular reimbursement and health policy related issues. With over 15 years of experience in market access strategy, Cara is well-versed in commercial payer and Medicare policies related to physician services and hospital inpatient, outpatient, and physician office-based procedures.
Prior to joining HeartFlow, Cara worked at Elekta as the Sr. Director of Global Policy and at Bayer Healthcare as manager of reimbursement and health policy for their interventional radiology and cardiology divisions. Before Bayer, she advised pharmaceutical, biotechnology, and medical device companies on Medicare and private payer coding, coverage and reimbursement issues at the Neocure Group, a boutique medical technology consulting firm. Ms. Santillo holds a master’s degree from the University of Michigan’s School of Public Health in health management and policy and a BS in Nutritional Sciences from Cornell University with concentrations in public policy and economics.
Chief Technology Officer
Tim has 18 years of experience leading the development and market introduction of innovative healthcare technologies. He joined HeartFlow in 2010 and held various product, technology, and commercial leadership roles to build HeartFlow’s product and service. Previously, Tim led design engineering at Cameron Health (acquired by Boston Scientific) to bring the world’s first S-ICD from development to clinical use. He co-founded a company to develop custom-fit healthcare products and was a researcher in blood flow modeling from medical image data at Stanford. Tim holds over 140 patents and peer reviewed publications.
He received a B.S in engineering from Rensselaer Polytechnic Institute and M.S. in engineering from Stanford.
Executive Vice President and Chief Medical Officer
Campbell brings a wealth of experience to HeartFlow, where he serves as the Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA.
He received his A.B. from Harvard College and his M.D. from Harvard Medical School.
Senior Vice President, Marketing, International Sales & Customer Success
Shivanth brings over 15 years of experience in the medical technology industry, spanning a multitude of roles from global commercial and marketing leadership to strategy, sales, business development and regulatory affairs. Most recently, Shivanth had been leading Heartflow’s US commercial enablement team to help expand availability and awareness of Heartflow’s technologies to a growing number of patients with suspected coronary artery disease. Previously, he led global marketing and commercial teams at Medtronic’s cardiology and vascular businesses, spearheading multiple successful multichannel marketing campaigns and product launches.
Shivanth holds an MBA from Harvard Business School and a Master’s degree in Medical Devices and Diagnostic Engineering from the University of Southern California.
Senior Vice President, US Sales
Nathan is an accomplished sales leader with more than 18 years of healthcare experience. He has held a variety of positions spanning sales representative, sales training and development, managed care, and field clinical leadership. Most recently, Nathan worked at Medtronic where he was the Vice President of the U.S. Field Sales and Clinical organization for the Diabetes Operating Unit.
Nathan received his undergraduate degree and MBA from Cal Poly Humboldt State University.
Chief Legal & Compliance Officer
Angela brings over 25 years of invaluable public company and medtech legal and compliance experience to HeartFlow. Most recently, she served as the General Counsel, Chief Compliance Officer, and Corporate Secretary of Inari Medical, Inc., a publicly-traded medical device manufacturer, where she oversaw their legal and compliance functions and was a key member of the executive leadership team. During her time at Inari, the company achieved over $500 million in revenue through high growth, commercial expansion, and innovation following the initial public offering in May 2020. Her extensive background also includes roles at CoreLogic and at the law firms of Latham & Watkins, LLP and Fried Frank.
Angela holds a JD from the University of Florida and earned a BA in French from Stetson University. She is a member of the California Bar.
*Required fields
If you would like to request to have the HeartFlow Analysis available at a location near you, please submit your information below with details of the institution. We will share this information with the institution, but it will not guarantee HeartFlow will become available.
*Required fields
オンライン提出フォームから研究助成金を申請してください。
HeartFlow FFRCT 分析は、有資格の臨床医による臨床的に安定した症状のある冠状動脈疾患患者への使用を目的とした個別化された心臓検査です。 HeartFlow Analysis によって提供される情報は、資格のある臨床医が患者の病歴、症状、その他の診断検査、および臨床医の専門的判断と組み合わせて使用することを目的としています。
ハートフロー分析に関する追加の適応情報については、次のサイトをご覧ください。www.heartflow.com/indications.
さらに質問がある場合は、このメッセージを閉じてフォームに記入するか、サポート チームにお電話ください。: 877.478.3569.
The HeartFlow FFRCT Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease by qualified clinicians. The information provided by the HeartFlow Analysis is intended to be used by qualified clinicians in conjunction with the patient’s history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement.
For additional indication information about the HeartFlow Analysis, please visit www.heartflow.com/indications.
If you have additional questions, close out of this message to complete our form or call our support team: 877.478.3569.Please use our online submission form on the Clinical Research Page to apply for research grants.
Thank you for your interest!